Related Experiment Videos
Head and neck squamous cell carcinoma in childhood
M B de Carvalho1, J de A Sobrinho, A Rapoport
1Head & Neck Service, Heliópolis Hospital, São Paulo, Brazil.
Insights
Squamous cell carcinoma (SCC) in children under 15 is rare but treatable. Standard adult protocols, with adjusted margins and neck dissection, yielded good results in a small study, avoiding future radiation risks.
Area of Science:
- Oncology
- Pediatric Medicine
- Surgical Oncology
Background:
- Squamous cell carcinoma (SCC) is exceptionally rare in pediatric patients.
- Management of pediatric head and neck SCC lacks established guidelines due to limited case studies.
- Existing literature suggests aggressive disease with high recurrence rates in young patients.
Observation:
- Four pediatric patients (≤15 years) with head and neck SCC were treated between 1977-1995.
- Patients had no history of tobacco, ethanol abuse, or familial cancer.
- Genetic investigation included immunohistochemical analysis for p53 and c-erbB-2 oncogenes.
Findings:
- Early diagnosis was achieved in most cases.
- Treatment followed standard adult protocols with modified surgical margins and selective neck dissection.
- Excellent outcomes were observed, with one case exhibiting unusual aggressiveness.
Implications:
- Pediatric head and neck SCC can be managed effectively using modified adult treatment protocols.
- Surgical resection with wider margins and selective neck dissection may obviate the need for adjuvant radiotherapy.
- Further research with larger cohorts is needed to solidify definitive treatment recommendations for this rare pediatric malignancy.
Background:
Squamous cell carcinoma (SCC) of the head and neck region is rare in young patients and even less frequent in children 15 years or younger children. The patients reported in the literature are isolated cases and their management is always difficult because there is no large experience or a convincing theory to support treatment decisions for every child.
Procedures And Results:
Four patients aged 15 years or younger were treated for SCC of head and neck between 1977 and 1995 at the Head and Neck Service of Heliópolis Hospital, São Paulo, Brazil, and with this paper we are reporting our experience with their treatment, including a genetic investigation in two cases (immunohistochemical analysis using monoclonal antibodies against p53 and c-erbB-2 oncogenes). These patients had no history of tobacco or ethanol abuse and no history of cancer in their families. Many authors attribute an unusual aggressiveness to SCC in childhood, with propensity to locoregional recurrence and high death rates and therefore, propose aggressive multidisciplinary therapy. Our cases, with the exception of one, had an early diagnosis and were treated using the same method we use for adults; the results were very good.
Conclusions:
We recommend for these cases the same protocol as for older patients. In these cases, however, the primary lesion is resected with a safety margin which is usually 2 to 3 mm larger than usual safety margins and selective neck dissection is routinely indicated. This management is adopted in an attempt to avoid postoperative irradiation which may prove to be dangerous in the future for young patients. On the other hand, we recognize that due to a small number de patients, definitive treatment recommendations cannot be made at this time.